儿童二尖瓣手术生存预测因素:手术年龄对远期随访的影响
单中心回顾性研究纳入142例18岁以下初次二尖瓣修复或置换患儿,按年龄分三组。5年无移植生存率89%、10年88%;单变量和多变量分析显示年龄<1岁是死亡或移植的显著危险因素(P=0.044),年龄<1岁与再手术风险增加相关(aHR=3.38,P=0.009)。
要点
- 5年无移植生存率89%,10年88%。
- 年龄<1岁是死亡或移植的显著危险因素(P=0.044)。
- 年龄<1岁与再手术风险增加相关(aHR=3.38,P=0.009)。
核心结论
- 儿童二尖瓣手术的总体生存率和免于再手术率仍需改善。
- 低龄是二尖瓣修复或置换后死亡和再干预的显著危险因素,婴儿和新生儿死亡风险约为儿童的3倍。
研究设计与样本
- 单中心回顾性研究,纳入1982年7月至2020年4月在罗马Bambino Gesù儿童医院接受初次二尖瓣修复或置换的142例18岁以下患者。
- 排除完全性、过渡性或部分性房室间隔缺损及单心室生理患者。
- 按年龄分为3组:组1(<1岁)、组2(1-5岁)、组3(>5岁)。
- 复合主要结局为免于死亡或移植,次要结局为免于再次二尖瓣手术。
主要发现
- 5年无移植生存率为89%,10年无移植生存率为88%。
- 按年龄分层,组1结局较其他组差(log-rank检验P=0.105)。
- 单变量和多变量分析均显示年龄<1岁是死亡或移植的显著危险因素(P=0.044)。
- 年龄<1岁与再手术风险增加相关(aHR=3.38,P=0.009)。
- 遗传综合征(aHR=0.22)和术前EF%(aHR=0.97)为再手术的保护因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to elucidate predictors of death and reintervention after mitral valve (MV) surgery in children. METHODS: A single-centre retrospective study was performed enrolling 142 patients younger than 18 years who underwent primary index surgical mitral repair or replacement at Bambino Gesù Children's Hospital in Rome from July 1982 to April 2020. Patients with complete, transitional or partial atrioventricular septal defect and patients with single ventricle physiology were excluded. Patients were stratified according to the age group: group 1 (<1 year old), group 2 (1-5 years old) and group 3 (>5 years old). The composite primary outcome was freedom from death or transplant. The secondary outcome was freedom from redo MV surgery. RESULTS: Transplant-free survival was 89% at 5 years and 88% at 10 years. Stratified by age, group 1 had poorer outcome in comparison with other groups (log-rank test P = 0.105). Both univariate and multivariate analyses showed that age <1 year was a significant risk factor for death or transplant (P = 0.044). Age <1 year was associated with increased risk of reoperation (aHR = 3.38, P = 0.009), while the presence of genetic syndrome (aHR = 0.22) and preoperative EF% (aHR = 0.97) were protective factors for reoperation. CONCLUSIONS: The overall survival and freedom from reoperation in children undergoing MV surgery still need improvements. Younger age was a significant risk factor for death and reintervention both after repair and replacement of the MV. In particular, infants and neonates have a three-fold risk for death compared to children.
引用
- Brancaccio G, Trezzi M, Croci I, et al. Predictors of survival in paediatric mitral valve surgery: the impact of age at operation at late follow-up. Eur J Cardiothorac Surg. 2022. PMID: 35325092. doi:10.1093/ejcts/ezac183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。